Ellsworth Advisors’s Anterix ATEX Stock Holding History
Bought
Maintained
Sold
Other funds holding ATEX
OCAM
HCL
SCM
BCC
JCP
QF
Ellsworth Advisors's ATEX Position: Q2 2022 in Review
Ellsworth Advisors sold out of Anterix (ATEX) in Q2 2022, closing a stake of 8,176 shares — an estimated $468K sold.
Ellsworth Advisors first reported a position in ATEX in Q1 2022 and held it in 1 quarter. The position peaked at $468K in Q1 2022. 94 funds tracked by Wall St. Rank hold ATEX as of Q2 2022.
- Ellsworth Advisors reported no remaining Anterix position as of Q2 2022 after selling out during the quarter.
- Ellsworth Advisors sold 8,176 Anterix shares in Q2 2022, an estimated $468K.
- Ellsworth Advisors first reported a position in Anterix in Q1 2022 and held it in 1 quarter.
- Ellsworth Advisors's Anterix position peaked at $468K in Q1 2022.
- 94 funds tracked by Wall St. Rank held Anterix as of Q2 2022.
Based on Ellsworth Advisors's 13F filing for Q2 2022, filed 25 Jul 2022.